Ubs Asset Management Americas Inc Macrogenics Inc Transaction History

Ubs Asset Management Americas Inc

  • $477 Billion
  • Q2 2025

A detailed history of Ubs Asset Management Americas Inc transactions in Macrogenics Inc stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 219,000 shares of MGNX stock, worth $385,440. This represents 0.0% of its overall portfolio holdings.

Number of Shares
219,000
Holding current value
$385,440
% of portfolio
0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
BUY
$1.06 - $1.79 $232,140 - $392,010
219,000 New
219,000 $264,000
Q2 2024

Aug 13, 2024
BUY
$3.31 - $18.51 $135,319 - $756,725
40,882 Added 151.98%
67,782 $288,000
Q1 2024

May 15, 2024
BUY
$9.77 - $21.47 $262,813 - $577,543
26,900 New
26,900 $395,000
Q3 2022

Nov 14, 2022
SELL
$3.01 - $5.22 $56,575 - $98,115
-18,796 Reduced 38.43%
30,117 $0
Q3 2021

Nov 15, 2021
SELL
$19.74 - $28.7 $74,103 - $107,739
-3,754 Reduced 7.13%
48,913 $1.02 Million
Q2 2021

Aug 16, 2021
SELL
$20.49 - $35.63 $9,732 - $16,924
-475 Reduced 0.89%
52,667 $1.41 Million
Q1 2021

May 14, 2021
BUY
$18.99 - $33.2 $156,040 - $272,804
8,217 Added 18.29%
53,142 $1.69 Million
Q3 2020

Nov 13, 2020
BUY
$24.69 - $31.6 $80,736 - $103,332
3,270 Added 7.85%
44,925 $1.13 Million
Q2 2020

Aug 14, 2020
SELL
$5.2 - $29.12 $3.12 Million - $17.5 Million
-600,094 Reduced 93.51%
41,655 $1.16 Million
Q1 2020

May 15, 2020
SELL
$4.28 - $12.11 $366,830 - $1.04 Million
-85,708 Reduced 11.78%
641,749 $3.73 Million
Q4 2019

Feb 14, 2020
BUY
$7.95 - $12.27 $95,376 - $147,203
11,997 Added 1.68%
727,457 $7.91 Million
Q3 2019

Nov 14, 2019
BUY
$12.44 - $17.48 $20,513 - $28,824
1,649 Added 0.23%
715,460 $9.13 Million
Q2 2019

Aug 15, 2019
BUY
$14.51 - $19.71 $3.56 Million - $4.84 Million
245,313 Added 52.36%
713,811 $0
Q1 2019

May 14, 2019
SELL
$11.11 - $25.6 $574,442 - $1.32 Million
-51,705 Reduced 9.94%
468,498 $0
Q4 2018

Feb 13, 2019
BUY
$11.75 - $21.42 $482,772 - $880,083
41,087 Added 8.58%
520,203 $6.61 Million
Q3 2018

Nov 14, 2018
SELL
$19.26 - $23.46 $163,421 - $199,058
-8,485 Reduced 1.74%
479,116 $0
Q2 2018

Aug 14, 2018
BUY
$19.78 - $24.67 $2.81 Million - $3.51 Million
142,160 Added 41.15%
487,601 $0
Q1 2018

May 14, 2018
SELL
$18.89 - $32.46 $679,133 - $1.17 Million
-35,952 Reduced 9.43%
345,441 $0
Q4 2017

Feb 09, 2018
BUY
$16.19 - $20.3 $165,931 - $208,054
10,249 Added 2.76%
381,393 $0
Q3 2017

Nov 13, 2017
BUY
$15.52 - $18.94 $5.76 Million - $7.03 Million
371,144
371,144 $0

Others Institutions Holding MGNX

# of Institutions
118
Shares Held
52.3M
Call Options Held
55.3K
Put Options Held
35.9K
View Full List

About MACROGENICS INC

MGNX Quotes by TradingView
  • Ticker MGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,458,800
  • Market Cap $108M
  • Description
  • MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...
More about MGNX
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email